Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, Ro-associated Y3 pseudogene 1 (RNY3P1) is a non-coding RNA classified as a **pseudogene** of the Y RNA family, specifically related to the functional gene RNY3 (Ro-associated Y3 RNA)[3][6][5]. Pseudogenes are gene copies that have lost their ability to encode functional proteins due to disabling mutations and are often unexpressed or have limited function[6][8]. While parental Y RNAs such as RNY3 (hY3) are involved in the formation of ribonucleoprotein complexes (notably with Ro60) and contribute to processes such as DNA replication initiation and mRNA regulation[7][3][9], there is **no evidence that RNY3P1 encodes a functional RNA or protein**. Some expressed pseudogenes can act as competitive endogenous RNAs (ceRNAs), regulating gene expression by competing for shared microRNAs[2][4], or modulate RNA-binding proteins, but no such specific function has been described or validated for RNY3P1 in the current literature or databases. There are also **no known drug interactions, biomarker roles, or safety concerns** relating to RNY3P1, nor is it considered a direct therapeutic target[3][5][6]. **Key context:** - RNY3P1 is distinct from the functional gene RNY3 (RNA, Ro60-associated Y3), which has recognized roles in immune response and mRNA regulation, but the pseudogene form is presumed biologically inert unless future research identifies an expressible or regulatory function[3][7][2]. - If you are seeking information on a molecular target for drug discovery or therapeutic intervention, RNY3P1 should not be considered a direct target due to its current classification as a nonfunctional pseudogene[6][8]. If more targeted details on the functional gene (RNY3) are needed, please specify, as roles and interactions differ significantly between pseudogenes and their parental genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, Ro-associated Y3 pseudogene 1 (RNY3P1).